127 related articles for article (PubMed ID: 36312002)
1. Effectiveness and safety of human umbilical cord-mesenchymal stem cells for treating type 2 diabetes mellitus.
Lian XF; Lu DH; Liu HL; Liu YJ; Han XQ; Yang Y; Lin Y; Zeng QX; Huang ZJ; Xie F; Huang CH; Wu HM; Long AM; Deng LP; Zhang F
World J Diabetes; 2022 Oct; 13(10):877-887. PubMed ID: 36312002
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial.
Lian XF; Lu DH; Liu HL; Liu YJ; Yang Y; Lin Y; Xie F; Huang CH; Wu HM; Long AM; Hui CJ; Shi Y; Chen Y; Gao YF; Zhang F
World J Clin Cases; 2023 Jul; 11(21):5083-5096. PubMed ID: 37583846
[TBL] [Abstract][Full Text] [Related]
3. Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes.
Hu J; Wang Y; Gong H; Yu C; Guo C; Wang F; Yan S; Xu H
Exp Ther Med; 2016 Sep; 12(3):1857-1866. PubMed ID: 27588104
[TBL] [Abstract][Full Text] [Related]
4. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus.
Kong D; Zhuang X; Wang D; Qu H; Jiang Y; Li X; Wu W; Xiao J; Liu X; Liu J; Li A; Wang J; Dou A; Wang Y; Sun J; Lv H; Zhang G; Zhang X; Chen S; Ni Y; Zheng C
Clin Lab; 2014; 60(12):1969-76. PubMed ID: 25651730
[TBL] [Abstract][Full Text] [Related]
5. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide combined with human umbilical cord mesenchymal stem cell transplantation inhibits beta-cell apoptosis via mediating the ASK1/JNK/BAX pathway in rats with type 2 diabetes.
Wang W; Wu RD; Chen P; Xu XJ; Shi XZ; Huang LH; Shao ZL; Guo W
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3212. PubMed ID: 31411368
[TBL] [Abstract][Full Text] [Related]
7. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
Bao Y; Zhao Z; Gao H
Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
Yin Y; Hao H; Cheng Y; Zang L; Liu J; Gao J; Xue J; Xie Z; Zhang Q; Han W; Mu Y
Cell Death Dis; 2018 Jul; 9(7):760. PubMed ID: 29988034
[TBL] [Abstract][Full Text] [Related]
9. Human Umbilical Cord Mesenchymal Stem Cells to Treat Neuromyelitis Optica Spectrum Disorder (hUC-MSC-NMOSD): A Study Protocol for a Prospective, Multicenter, Randomized, Placebo-Controlled Clinical Trial.
Yao XY; Xie L; Cai Y; Zhang Y; Deng Y; Gao MC; Wang YS; Xu HM; Ding J; Wu YF; Zhao N; Wang Z; Song YY; Wang LP; Xie C; Li ZZ; Wan WB; Lin Y; Jin HF; Wang K; Qiu HY; Zhuang L; Zhou Y; Jin YY; Ni LP; Yan JL; Guo Q; Xue JH; Qian BY; Guan YT
Front Neurol; 2022; 13():860083. PubMed ID: 35547390
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats.
Yap SK; Tan KL; Abd Rahaman NY; Saulol Hamid NF; Ooi J; Tor YS; Daniel Looi QH; Stella Tan LK; How CW; Foo JB
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336023
[TBL] [Abstract][Full Text] [Related]
11. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study.
Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL
Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
Xu X; Wang W; Lin L; Chen P
Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
[TBL] [Abstract][Full Text] [Related]
13. Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus.
Wang RR; Lv ZM; Dan YP; Chen KY; Zhang C
J Biol Regul Homeost Agents; 2019; 33(2):365-374. PubMed ID: 30972995
[TBL] [Abstract][Full Text] [Related]
14. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of stem cells from human exfoliated deciduous teeth infusion into patients with type 2 diabetes depends on basal lipid levels and islet function.
Li W; Jiao X; Song J; Sui B; Guo Z; Zhao Y; Li J; Shi S; Huang Q
Stem Cells Transl Med; 2021 Jul; 10(7):956-967. PubMed ID: 33660433
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma homocysteine levels and pancreatic islet beta-cell function in the patients with type 2 diabetes mellitus: a cross-sectional study from China.
Yuan X; Ding S; Zhou L; Wen S; Du A; Diao J
Ann Palliat Med; 2021 Jul; 10(7):8169-8179. PubMed ID: 34353101
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
18. Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge.
Feng G; Shi L; Huang T; Ji N; Zheng Y; Lin H; Niu C; Wang Y; Li R; Huang M; Chen X; Shu L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J
Stem Cells Dev; 2021 Aug; 30(15):773-781. PubMed ID: 34044609
[TBL] [Abstract][Full Text] [Related]
19. Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: A two-year follow-up.
Wang X; Yin X; Sun W; Bai J; Shen Y; Ao Q; Gu Y; Liu Y
Exp Ther Med; 2017 May; 13(5):2255-2258. PubMed ID: 28565834
[TBL] [Abstract][Full Text] [Related]
20. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
